Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
(PubMed) Vijayakumar K, Gunny R, Grunewald S, et al
TEAEs occurred in 5/6 (83.3%) participants in each PG-102 cohort and 4/6 (66.7%) in placebo
2o), which may underlie the pathogenesis of FEVR
The gut and recovery indications are particularly well-matched to the female patient profile we see in South Florida, where many patients are combining BPC-157 with other regenerative protocols or recovering from aesthetic procedures
Further, those with higher B12 levels and taking high dose vitamins had better outcomes with stroke, death, and heart events compared to those with lower B12 levels and taking low dose vitamins (3)
ONCOBIOTICS (NCT04567446) is a multicenter observational study involving 14 participating centers in France and Canada, encompassing the IMMUNOLIFE (IML1) cohort, aiming to discover microbiome-based biomarkers in patients with cancer
